Who benefits from adjuvant chemotherapy? Identification of early recurrence in intrahepatic cholangiocarcinoma patients after curative-intent resection using machine learning algorithms
ObjectiveIt is vital to enhance the identification of early recurrence in intrahepatic cholangiocarcinoma (ICC) patients after curative-intent resection and to determine which patients could benefit from adjuvant chemotherapy (ACT). This study aimed to evaluate the effectiveness of machine learning...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1594200/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|